FDA Approves $3.1M Gene Therapy for Rare, Painful Skin DisorderThe FDA has approved Zevaskyn for treating recessive dystrophic epidermolysis bullosa, a rare skin condition, promising improved healing.
New Drug Helps Patients with Myasthenia Gravis Breathe and Speak EasierThe FDA has approved Johnson & Johnson's Imaavy for myasthenia gravis, benefiting over 90% of patients and improving daily tasks.
New FDA-Approved Pill Targets Constant Hunger in Children with PWSFDA approves Soleno's Vykat XR for treating hyperphagia in Prader-Willi Syndrome, aiming to improve patients' quality of life.
Neurocrine's New CAH Drug, Krenicity, Gets FDA Approval—Here’s What You Need to KnowFDA approves Neurocrine Biosciences' Krenicity for congenital adrenal hyperplasia, reducing glucocorticoid dosage in patients.
Must-Reads
1
Trump Claims Epstein 'Stole' Young Women from Mar-a-Lago Spa
LATEST
2
Say Hello to Your New Beauty Buddy: AI-Powered Kiosks Hit GS25 Stores!
LATEST
3
New Task Force Takes Aim at Stock Manipulators: A Game Changer for Investors!
LATEST
4
COP30 Chaos: Will Brazil's Soaring Hotel Prices Keep Poor Nations Out of Climate Talks?
LATEST
5
Is Tesla Behind LG Energy's Massive Battery Supply Contract?
Hot Topics